share_log

Barrington Research:维持Anika Therapeutics(ANIK.US)评级,由优于大市调整至优于大市评级, 目标价由37.00美元调整至37.00美元。

Zhitong Finance ·  May 9 12:25

Barrington Research:维持Anika Therapeutics(ANIK.US)评级,由优于大市调整至优于大市评级, 目标价由37.00美元调整至37.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment